Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

A new study suggests that treating gum disease within three months of a heart procedure for atrial fibrillation (AFib) may ...